Alabama
Birmingham; Cardiothoracic Surgery ,University of Alabama, Birmingham
The IBV® Valve Trial
A research study for people suffering from Emphysema.
Birmingham; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Mobile; Pulmonary Associates of Mobile, PC
The IBV® Valve Trial
A research study for people suffering from Emphysema.
Arizona
Phoenix; Pulmonary Associates Phoenix
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
California
Los Angeles; UCLA David Geffen School of Medicine
The IBV® Valve Trial
A research study for people suffering from Emphysema.
Los Angeles; Cedars-Sinai Medical Center
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
Los Angeles; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Mission Viejo; Mission Internal Medicine Group
The IBV® Valve Trial. An investigational treatment for people suffering from Emphysema.
Sacramento ; UC Davis Medical Center
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
Sacramento; UC Davis Medical Center
The IBV® Valve Trial
A research study for people suffering from Emphysema.
San Diego ; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Torrance ; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Colorado
Denver; National Jewish Medical and Research Center
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
Denver; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Florida
Panama City; Emerald Coast Research Associates
Are you a current or former smoker who has been diagnosed with emphysema or chronic bronchitis?
Sarasota; Clinical Research Center at Sarasota Memorial Hospital
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
Georgia
Atlanta; Emory Healthcare
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
Atlanta; The Emory Clinic, Emory University
The IBV® Valve Trial
A research study for people suffering from Emphysema.
Illinois
Chicago; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Elk Grove Village; Alexian
The IBV® Valve Trial
A research study for people suffering from Emphysema.
Peoria; Peoria Pulmonary Associates
The EASE Trial: An investigation of the Exhale ® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
Springfield; Southern Illinois University Medical Center
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
Winfield; Chicago Chest Center at Central DuPage Hospital
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
Iowa
Iowa City; University of Iowa Hospitals and Clinics
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
Kansas
Olathe; Consultants in Pulmonary Medicine
The IBV® Valve Trial
A research study for people suffering from Emphysema.
Topeka; Veritas Clinical Specialties/Topeka Pulmonary
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
Kentucky
Louisville; University of Louisville
The IBV® Valve Trial. An investigational treatment for people suffering from Emphysema.
Louisiana
Slidell; Medical Research Institute, Inc.
Do You Suffer From Chronic Bronchitis Or Emphysema?
Maryland
Baltimore; Pulmonary and Critical Care Associates of Baltimore
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
Baltimore; Pulmonary and Critical Care Associates of Baltimore
The IBV® Valve Trial. An investigational treatment for people suffering from Emphysema.
Massachusetts
Boston; BWH - Brigham and Women's Hospital
The Effect of Chronic Macrolide Administration on the Frequency and Severity of COPD Exacerbations
Boston; Boston Medical Center
The IBV® Valve Trial. An investigational treatment for people suffering from Emphysema.
Michigan
Ann Arbor; ClinSite, LLC
7 month chronic bronchitis or emphysema (COPD) research study
Ann Arbor; ClinSite, LLC
Are you a current or former smoker who has noticed changes in your breathing?
Detroit; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Detroit; Henry Ford Hospital
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
Minnesota
St.Paul; Health Partners Specialty Ctr, Lung&Sleep Health Clinic
The IBV® Valve Trial
A research study for people suffering from Emphysema..
Nebraska
Omaha; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
New Jersey
Summit; Pulmonary and Allergy Associates
The IBV® Valve Trial
A research study for people suffering from Emphysema.
New York
Albany; Pulmonary and Critical Care Services, P.C.
New investigational medication for COPD/Emphysema
Brooklyn; New York Methodist Hospital
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
Endwell; Regional Clinical Research, Inc.
Do you have any of these problems? Shortness of Breath? Cough? Chronic Bronchitis? Emphysema? Wheezing? Phlegm? Chronic Obstructive Pulmonary Disease?
New York; New York University School of Medicine
The IBV® Valve Trial. An investigational treatment for people suffering from Emphysema.
New York; NewYork-Presbyterian/Columbia University Medical Center
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
New York; Mt. Sinai School of Medicine
The IBV® Valve Trial
A research study for people suffering from Emphysema.
North Carolina
Durham; Duke University Medical Center
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
Ohio
Cleveland; Cleveland Clinic Foundation
The IBV® Valve Trial
A research study for people suffering from Emphysema.
Cleveland; Cleveland Clinic Foundation
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
Oklahoma
Oklahoma City; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Tulsa; Oklahoma State
The IBV® Valve Trial
A research study for people suffering from Emphysema.
Pennsylvania
Allentown; Lehigh Valley Hospital
The IBV® Valve Trial
A research study for people suffering from Emphysema.
Philadelphia; Hospital of the University of Pennsylvania
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
Philadelphia; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Philadelphia; University of Pennsylvania
The IBV® Valve Trial
A research study for people suffering from Emphysema.
Rhode Island
Providence; Rhode Island Hospital
The IBV® Valve Trial
A research study for people suffering from Emphysema.
South Carolina
Spartanburg; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Texas
Houston; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
San Antonio; Sun Research Institute
Do you have COPD? If so, you may qualify to participate in a 28 week research study.
San Antonio; Sun Research Institute
Volunteers needed for three year research study of an investigational medicine for Emphysema or Chronic Bronchitis (COPD).
Utah
Salt Lake City; University of Utah Health Sciences Center
The IBV® Valve Trial
A research study for people suffering from Emphysema.
Virginia
Charlottesville; University of Virginia
The VITAL- Valve Intervention Treatment Trial
Charlottesville; University of Virginia
Hyperpolarized Helium-3 MR Lung Imaging in Patients with Chronic Obstructive Pulmonary Disease, Patients with Lung Lesions, and Healthy Volunteers. HIC #: 8973
Norfolk; Sentara Norfolk General Hospital
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation
International
Fitzroy, Australia; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
Leuven, Belgium; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
Pleven, Bulgaria; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Ruse, Bulgaria; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Sofia, Bulgaria; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Toronto, ON, Canada; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
Vancouver, BC, Canada; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
Karlovy Vary, Czech Republic; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Ostrava, Czech Republic; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Praha, Czech Republic; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Tabor, Czech Republic; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Hellerup, Denmark; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
Marburg, Germany; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
Balassagyarmat, Hungary; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Budapest, Hungary; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Pecs, Hungary; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Szombathely, Hungary; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Torokbalint, Hungary; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Reykjavik, Iceland; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Ashkelon, Israel; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Haifa, Israel; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Petah Tikva, Israel; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Ramat Gan, Israel; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Rehovot, Israel; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Tel Aviv, Israel; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Genova, Italy; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Modena, Italy; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Pavia, Italy; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Pisa, Italy; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Daugavpils, Latvia; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Riga, Latvia; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Almelo, Netherlands; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
Leiden, Netherlands; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
Maastricht, Netherlands; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
Otahuhu, New Zealand; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
Bialystok, Poland; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Katowice, Poland; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Lodz, Poland; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Poznan, Poland; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Warszawa, Poland; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Amanzimtoti, South Africa; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Bellville, South Africa; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Bloemfontein, South Africa; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Cape Town, South Africa; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Centurion, South Africa; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Durban, South Africa; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Worcester, South Africa; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Barakaldo, Spain; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
Vigo, Spain; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
Malmoe, Sweden; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
Zürich, Switzerland; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
Donetsk, Ukraine; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Kiev, Ukraine; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Birmingham, United Kingdom; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
Cambridge, United Kingdom; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
Coventry, United Kingdom; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)
Edinburgh, United Kingdom; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)
